Clearside Biomedical Inc (CLSD)
1.34
+0.08
(+6.35%)
USD |
NASDAQ |
Apr 26, 16:00
1.30
-0.04
(-2.99%)
After-Hours: 20:00
Clearside Biomedical Max Drawdown (5Y): 97.63% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 97.63% |
| February 29, 2024 | 97.63% |
| January 31, 2024 | 97.63% |
| December 31, 2023 | 97.63% |
| November 30, 2023 | 97.63% |
| October 31, 2023 | 97.63% |
| September 30, 2023 | 97.63% |
| August 31, 2023 | 97.63% |
| July 31, 2023 | 97.63% |
| June 30, 2023 | 97.63% |
| May 31, 2023 | 97.63% |
| April 30, 2023 | 97.63% |
| March 31, 2023 | 97.63% |
| February 28, 2023 | 97.63% |
| January 31, 2023 | 97.63% |
| December 31, 2022 | 97.63% |
| November 30, 2022 | 97.63% |
| October 31, 2022 | 97.63% |
| September 30, 2022 | 97.63% |
| August 31, 2022 | 97.63% |
| July 31, 2022 | 97.63% |
| June 30, 2022 | 97.63% |
| May 31, 2022 | 97.63% |
| April 30, 2022 | 97.63% |
| March 31, 2022 | 97.63% |
| Date | Value |
|---|---|
| February 28, 2022 | 97.63% |
| January 31, 2022 | 97.63% |
| December 31, 2021 | 97.63% |
| November 30, 2021 | 97.63% |
| October 31, 2021 | 97.63% |
| September 30, 2021 | 97.63% |
| August 31, 2021 | 97.63% |
| July 31, 2021 | 97.63% |
| June 30, 2021 | 97.63% |
| May 31, 2021 | 97.63% |
| April 30, 2021 | 97.63% |
| March 31, 2021 | 97.63% |
| February 28, 2021 | 97.63% |
| January 31, 2021 | 97.63% |
| December 31, 2020 | 97.63% |
| November 30, 2020 | 97.63% |
| October 31, 2020 | 97.63% |
| September 30, 2020 | 97.63% |
| August 31, 2020 | 97.63% |
| July 31, 2020 | 97.63% |
| June 30, 2020 | 97.63% |
| May 31, 2020 | 97.63% |
| April 30, 2020 | 97.63% |
| March 31, 2020 | 97.63% |
| February 29, 2020 | 97.63% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.95%
Minimum
Apr 2019
97.63%
Maximum
Sep 2019
97.52%
Average
97.63%
Median
Sep 2019
Max Drawdown (5Y) Benchmarks
| Cassava Sciences Inc | 96.61% |
| Heron Therapeutics Inc | 98.09% |
| Actinium Pharmaceuticals Inc | 97.29% |
| Karyopharm Therapeutics Inc | 97.56% |
| Ocular Therapeutix Inc | 94.06% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -29.77 |
| Beta (5Y) | 2.287 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 106.1% |
| Historical Sharpe Ratio (5Y) | 0.0008 |
| Historical Sortino (5Y) | 0.0023 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.80% |